Efficacy of anti-CD20 chimeric Fab′ fragment on proliferation of B lymphoma cells

Chinese Science Bulletin

Volumn 46, Issue 14, 2001, Pages 1182-1186

  Lai, Z ^a   Xiong, D ^a   Fan, D ^a   Xu, Y ^a   Liu, H ^a   Peng, H ^a   Zhu, Z ^a   Yang, C ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

Author keywords

B lymphoma; CD20; Chimeric Fab ; Monoclonal antibody

Indexed keywords

CD20 ANTIGEN; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY HI47; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ANTIBODY PRODUCTION; ARTICLE; B CELL LYMPHOMA; CELL PROLIFERATION; CHIMERA; COMPETITIVE INHIBITION; DAUDI CELL; DRUG EFFICACY; ESCHERICHIA COLI; EXPRESSION VECTOR; GENE CONSTRUCT; HUMAN; HUMAN CELL; IC 50; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOMODULATION; MOLECULAR CLONING; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN DOMAIN; PROTEIN PURIFICATION;

EID: 0034911930     PISSN: 10016538     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02900598     Document Type: Article

References (16)

1. 1 phase of the cell cycle
2. Characterization of a human B lymphocyte specific antigen
3. B cell origin of non-T cell acute lymphoblasticleukemia a model for discrete stages of neoplastic and normal pre-B cell differentiation
4. Expression of cell surface markers of ter humen B lymphcyte activation
5. CD20: A review
6. Molecular cloning of the human B cell CD20 receptor predicts a hydrophobic protein with multiple transmembrane domains
7. Endocytosis and degradation of monoclonal antibodies targeting human B-cell malignancies
8. Retention of B-cell-specific monoclonal antibodies by human lymphoma cells
9. 47 against mature B cells
10. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: Half of patients respond to a four-dose treatment program
11. Yttrium-90-labeled anti-CD20 monoclonal antibody therapy of recurrent B cell lymphoma
12. Treatment of patients with low grade B cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy
13. 131I-B1(anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas
14. I-131 anti-B1 antibody for previously untreated follicular lymphoma: Clinical and molecular remissions
15. 47(CD20) on activation and proliferation of B cells
16. Apoptosis of malignane human B cell by ligation of CD20 with monoclonal antibodies